Invited by the financial and economic channel Kanaal Z on 15th April, our CEO Hans Cobben talks with Veronique Goossens.
Veronique starts with noting Hans’ previous experience in the financial sector and how that knowledge positions BlueBee, a High Performance Genomics company, as a key player in the genomics industry.
Hans then talks about how the BlueBee solution can efficiently processes genetic data and how it brings the personalized medicine concept closer to the hospitals. The raw genome information generated by the hospital’s sequencers requires intense computing power to process the data and to deliver results. What sets BlueBee apart is the efficiency of its data analysis and the secured user convenience that allows clinicians to offer the genome analysis to their patients in a cost effective way. The benefits from a genome analysis will no longer be only available to the happy few but to many more patients worldwide.
BlueBee recently announced the €10M in Series A funding, which highlights the company’s expertise and dedication to drive the high performance genomics platform forward.
The video recording, which is in Dutch can be seen here: http://knack.be/s/r/c/692143